Mitsubishi UFJ Asset Management Co., Ltd. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$583,163
-36.2%
183,9630.0%0.00%
-50.0%
Q2 2023$914,296
+11.9%
183,963
+11.2%
0.00%0.0%
Q1 2023$816,967
-13.2%
165,378
+1.2%
0.00%
-33.3%
Q4 2022$941,443
-49.4%
163,445
-5.1%
0.00%
-50.0%
Q3 2022$1,860,000
-5.0%
172,223
+0.3%
0.01%
-33.3%
Q2 2022$1,958,000
+37.1%
171,742
+9.6%
0.01%
+50.0%
Q1 2022$1,428,000
-39.7%
156,700
+1.2%
0.01%
-33.3%
Q4 2021$2,367,000
-9.1%
154,826
+52.7%
0.01%
-30.8%
Q3 2021$2,605,000
-1.5%
101,3730.0%0.01%
-7.1%
Q2 2021$2,644,000
+25.5%
101,373
+69.8%
0.01%0.0%
Q1 2021$2,107,000
+49.3%
59,685
+6.8%
0.01%
+27.3%
Q4 2020$1,411,000
+21.8%
55,900
+82.0%
0.01%0.0%
Q3 2020$1,158,000
+39.9%
30,713
+58.7%
0.01%
+22.2%
Q2 2020$828,000
+3.9%
19,347
-52.8%
0.01%
-25.0%
Q1 2020$797,000
+28.5%
40,985
+71.7%
0.01%
+50.0%
Q4 2019$620,000
+339.7%
23,875
+362.4%
0.01%
+300.0%
Q3 2019$141,000
+25.9%
5,163
+23.8%
0.00%0.0%
Q2 2019$112,0004,1690.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders